Tom Bell is a Partner in L.E.K. Consulting’s London office. A member of the Life Sciences practice, Tom focuses on biotech and biopharma corporate strategy, portfolio strategy, M&A and value creation. He also has a focus on contract services for biopharma, including CROs and contract commercialization organizations. He has led numerous projects within the life sciences industry for biotech, large and midsize pharma, and contract services providers, and for investors in both public and private companies. Tom has conducted various market and commercial opportunity assessments in oncology, immunology, respiratory, rare disease, and other areas, including for advanced modalities such as cell and gene therapy.
Tom holds a Ph.D. in immunology and a B.Sc. and an MRes in biochemistry from Imperial College London.
Education
Undergraduate: Bachelor of Science in Biochemistry, Imperial College London
Graduate: Master of Research, Ph.D. in Immunology, Imperial College London
